跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL
Approved
STANDARD
EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 21, 2021
Approval ID
04917301db44874e
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
04917301db44874e
Drug Cima Aemps Name
EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL
Register Number
1211531001
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Roche Farma S.A.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2021-04-21
Dosage Form
POLVO PARA SOLUCIÓN ORAL
Dose
0,75 mg/ml
Route Of Administration
VÍA ORAL, VÍA GASTROENTÉRICA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
RISDIPLAM
0,75 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 21, 2021
Approval ID
04917301db44874e
Type
Standard
Back to CIMA-AEMPS Approvals
